The EMA says a study did not show clinical benefit, while Sanofi says it will continue to work closely with the regulator to bring the treatment to patients.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/europe-rejects-graft-vs-host-disease-therapy-2025a1000s9j?src=rss
Author :
Publish date : 2025-10-17 15:23:00
Copyright for syndicated content belongs to the linked Source.
